Phase II clinical study of hexestrol (NSC-9894)

Cancer Chemother Rep. 1968 Dec;52(7):751-3.
No abstract available

MeSH terms

  • Female
  • Hexestrol / adverse effects
  • Hexestrol / therapeutic use*
  • Humans
  • Male
  • Neoplasms / drug therapy*

Substances

  • Hexestrol